High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosis

Dimethyl fumarate (DMF) is an immunomodulatory treatment for multiple sclerosis (MS). Despite its wide clinical use, the mechanisms underlying clinical response are not understood. This study aimed to reveal immune markers of therapeutic response to DMF treatment in MS. For this purpose, we prospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Diebold, Martin, Galli, Edoardo, Kopf, Andreas, Sanderson, Nicholas S R, Callegari, Ilaria, Benkert, Pascal, Gonzalo Núñez, Nicolás, Ingelfinger, Florian, Herms, Stefan, Cichon, Sven, Kappos, Ludwig, Kuhle, Jens, Becher, Burkhard, Claassen, Manfred, Derfuss, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351505/
https://www.ncbi.nlm.nih.gov/pubmed/35881799
http://dx.doi.org/10.1073/pnas.2205042119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351505/
https://www.ncbi.nlm.nih.gov/pubmed/35881799
http://dx.doi.org/10.1073/pnas.2205042119

Ejemplares similares